In this study, we demonstrated for the first time that AMIGO2-containing EVs derived from AMIGO2-expressing cancer cells were treated with liver endothelial cells, significantly enhancing their adhesion to cancer cells. The gene discussed is AMIGO2; the disease is cancer.